Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series

INTRODUCTION: While improvements have been made to risk assessment of cutaneous squamous cell carcinoma (cSCC) patients, there is a critical need for a uniform and more precise stratification system of their care. To address this unmet clinical need, a prognostic 40-gene expression profile (40-GEP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Jeremiah H., Hooper, Perry B., Fitzgerald, Alison L., Somani, Ally-Khan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850491/
https://www.ncbi.nlm.nih.gov/pubmed/34951694
http://dx.doi.org/10.1007/s13555-021-00665-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850491/
https://www.ncbi.nlm.nih.gov/pubmed/34951694
http://dx.doi.org/10.1007/s13555-021-00665-y

Ejemplares similares